Aclidinium Bromide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: Aclidinium bromide;   Drug: PlaceboSponsor:    Almirall, S.A.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2014 Category: Research Source Type: clinical trials

A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Chronic Obstructive Pulmonary Disease (COPD)Interventions:   Drug: Aclidinium bromide;   Drug: PlaceboSponsor:    Almirall, S.A.Recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2014 Category: Research Source Type: clinical trials

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD
Conditions:   COPD;   Chronic Obstructive Pulmonary DiseaseInterventions:   Drug: Aclidinium Bromide;   Drug: PlaceboSponsor:   Forest LaboratoriesRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2013 Category: Research Source Type: clinical trials

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD
Conditions:   COPD;   Chronic Obstructive Pulmonary DiseaseInterventions:   Drug: Aclidinium Bromide;   Drug: PlaceboSponsor:   Forest LaboratoriesRecruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2013 Category: Research Source Type: clinical trials

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD
Conditions:   COPD;   Chronic Obstructive Pulmonary DiseaseInterventions:   Drug: Aclidinium Bromide;   Drug: PlaceboSponsor:   Forest LaboratoriesRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2013 Category: Research Source Type: clinical trials